Public Health - Medetomidine and Xylazine Consumer Protection Act
Motion Laid Over (Senator Ready) Adopted (Senate)
Email me when SB 435 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track SB 435. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill bars any retailer from selling or displaying medetomidine or xylazine products unless the purchaser shows proof the drug will be used for institutional, veterinary, or scientific purposes and is at least 21 years old. Retailers must keep records of the age verification and the intended‑use documentation, and violations carry civil fines that go to the Maryland Substance Abuse Fund. The law aims to curb misuse of these substances and protect public health.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about SB 435
3 free questions a day, no accountHearings
- Finance — Bill HearingFinance · Feb 11, 2026
History
- Motion Laid Over (Senator Ready) Adopted
- Favorable with Amendments Report by Finance
- Favorable with Amendments {
- Hearing 2/11 at 2:00 p.m.
- First Reading Finance
Sponsors
- Folden · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when SB 435 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track SB 435 freeOr ask your AI assistant about SB 435 directly:
Add to Claude, ChatGPT or Cursor